The ATM facility provides Coya with flexible access to capital but introduces ongoing dilution risk. Monitor the company's cash burn rate and any subsequent disclosures of shares sold under the facility. The concurrent 424B5 filing confirms this is a capital raise event — watch for actual sales volume in future filings.
Price Chart
Executive Summary
Coya Therapeutics entered into an at-the-market (ATM) equity sales agreement with Leerink Partners LLC, allowing the company to sell up to $30 million of its common stock over time. The filing is purely a capital-raising mechanism with no operational or financial results disclosed, and it is filed concurrently with a 424B5 prospectus supplement for the same ATM offering.
Key Financial Metrics
Key Facts
- Coya Therapeutics entered into a Sales Agreement with Leerink Partners LLC on May 12, 2026.
- The company may offer and sell up to $30,000,000 of common stock in at-the-market offerings.
- Leerink Partners will receive a 3.0% commission on gross proceeds from shares sold.
- The ATM offering is made under an existing effective shelf registration statement (File No. 333-289511).
- The company is an emerging growth company and has no obligation to sell any shares under the agreement.
- A 424B5 prospectus supplement for the same $30M ATM offering was filed on the same date.
Financial Impact
Up to $30,000,000 in potential gross proceeds from common stock sales, with a 3.0% commission to Leerink Partners.
Risk Factors
- Potential dilution to existing shareholders as shares are sold into the market.
- ATM sales may pressure the stock price if executed aggressively.
- No guarantee of capital raise — the company may not sell any shares under the agreement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-218282 |
| Document: d938051d8k.htm | 0001193125-26-218282 |
| Document: d938051dex51.htm | 0001193125-26-218282 |
| Document: 0001193125-26-218282-index-headers.html | 0001193125-26-218282 |
| Document: 0001193125-26-218282-index.html | 0001193125-26-218282 |
| Document: 0001193125-26-218282.txt | 0001193125-26-218282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $4.18 | awaiting T+20 | — | $4.12 (−1.44%) |
Oct 5, 2026 22d ago | 8-K | $4.85 | awaiting T+20 | — | $4.12 (−15.05%) |
Sep 15, 2026 6w ago | 8-K | $4.65 $4.48 | ▼ −3.76% | ▼ −6.74% | $4.12 (−11.40%) |
Aug 11, 2026 11w ago | 8-K | $4.80 $4.61 | ▼ −3.96% | ▼ −2.90% | $4.12 (−14.17%) |
May 12, 2026 24w ago | 8-K | $4.29 $4.41 | ▲ +2.80% | ▲ +4.52% | $4.12 (−3.96%) |
Apr 2, 2026 29w ago | 8-K | $4.01 $4.23 | ▲ +5.49% | ▼ −4.39% | $4.12 (+2.74%) |
Mar 23, 2026 31w ago | EFFECT | $4.22 $4.53 | ▲ +7.35% | ▼ −0.07% | $4.12 (−2.37%) |
Mar 16, 2026 32w ago | S-3 | $4.50 $4.46 | ▼ −0.89% | ▼ −4.67% | $4.12 (−8.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers